Flowing through the CRISPR-CAScade: Will genome editing boost cell therapies?

Uri Ben-David

doi:10.1186/2052-8426-1-3

Flowing through the CRISPR-CAScade: Will genome editing boost cell therapies?

Uri Ben-David

Human Molecular Genetics Biochemistry

Tel Aviv University

Research output: Contribution to journal › Comment/debate

Abstract

Recent years have seen great advancements in genome editing technologies, allowing for efficient and specific targeting of DNA sequences into the genome. In parallel, advancements in stem cell research, and especially the ability to induce pluripotency in somatic cells, have brought stem cell-derived therapies closer to the clinic. In this commentary, I envision how groundbreaking genome editing technologies will influence stem cell biology research, paving the way to regenerative medicine with genetically engineered cells.

Original language	English
Pages (from-to)	3
Journal	Molecular and cellular therapies
Volume	1
DOIs	https://doi.org/10.1186/2052-8426-1-3
State	Published - 2013

Access to Document

10.1186/2052-8426-1-3

Cite this

@article{5625a42b0b2d44d0a7c8e80a7235eb94,

title = "Flowing through the CRISPR-CAScade: Will genome editing boost cell therapies?",

abstract = "Recent years have seen great advancements in genome editing technologies, allowing for efficient and specific targeting of DNA sequences into the genome. In parallel, advancements in stem cell research, and especially the ability to induce pluripotency in somatic cells, have brought stem cell-derived therapies closer to the clinic. In this commentary, I envision how groundbreaking genome editing technologies will influence stem cell biology research, paving the way to regenerative medicine with genetically engineered cells. ",

author = "Uri Ben-David",

year = "2013",

doi = "10.1186/2052-8426-1-3",

language = "الإنجليزيّة",

volume = "1",

pages = "3",

journal = "Molecular and cellular therapies",

issn = "2052-8426",

publisher = "Cell Press",

}

TY - JOUR

T1 - Flowing through the CRISPR-CAScade

T2 - Will genome editing boost cell therapies?

AU - Ben-David, Uri

PY - 2013

Y1 - 2013

N2 - Recent years have seen great advancements in genome editing technologies, allowing for efficient and specific targeting of DNA sequences into the genome. In parallel, advancements in stem cell research, and especially the ability to induce pluripotency in somatic cells, have brought stem cell-derived therapies closer to the clinic. In this commentary, I envision how groundbreaking genome editing technologies will influence stem cell biology research, paving the way to regenerative medicine with genetically engineered cells.

AB - Recent years have seen great advancements in genome editing technologies, allowing for efficient and specific targeting of DNA sequences into the genome. In parallel, advancements in stem cell research, and especially the ability to induce pluripotency in somatic cells, have brought stem cell-derived therapies closer to the clinic. In this commentary, I envision how groundbreaking genome editing technologies will influence stem cell biology research, paving the way to regenerative medicine with genetically engineered cells.

U2 - 10.1186/2052-8426-1-3

DO - 10.1186/2052-8426-1-3

M3 - تعليقَ / نقاش

C2 - 26056569

SN - 2052-8426

VL - 1

SP - 3

JO - Molecular and cellular therapies

JF - Molecular and cellular therapies

ER -

Flowing through the CRISPR-CAScade: Will genome editing boost cell therapies?

Abstract

Access to Document

Fingerprint

Cite this